欢迎访问《现代生物医学进展》编辑部！

目的：探讨甲状腺功能亢进性心脏病的防治措施。方法：回顾性分析2003 年6 月至2009 年6 月收治的46 例甲状腺功能抗进性心脏病患者的临床资料。其中男20 例，女26 例，年龄15-78 岁，病程7 月-30 年；伴心功能衰竭28 例(60.9％)，心房纤颤30 例(65.2％)，和病态窦房结综合征1 例(2.2％)。结果：46 例患者均服用甲状腺药物治疗后,甲亢病情缓解, 心力衰竭好转。30 例心房纤颤患者中,19 例恢复窦性心律, 剩余11 例平均心室率控制在70-100 次/min。结论：甲亢性心脏病治疗的关键在于早期诊断,甲亢病情控制后, 绝大部分心脏异常可减轻或消失。

英文摘要:

Objective : To investigate the prophylactico-therapeutic measures with hyperthyroid cardiopathy. Methods：The clinical data of 46 patients with thyrotoxic cardiopathy in hospital from June 2003 to June 2009，20 males and 26 females，aged 15--78 years old，with the course from 7 month to 30 years，were analyzed retrospectivelv.Twenty-eight of the 46 patients (60.9％)presented heart failure，30 patients (65.2％)showed atrial fibrillation，1 patients (2.2％)showed sick sinus syndrome. Results：The 46 patients with thyrotoxicosis condition and heart failure were improved by pharmacological treatmen.t 19 cases of 30 cases with atrial fibrillation restored sinus rhythm, the heart rate of o ther 11 cases was controlled by 70-100tmies /min. Conclusion：The key to the treatment o f hyperthyroid cardiopathy is to be diagnosed early and control thyrotoxicosis as quickly as possible. Most of heart disorder can lighten or disappear after thyrotoxicosis is controlled.

View Full Text View/Add Comment Download reader